Promising new Alzheimer's drugs may be less effective for Black patients
|
The
two drugs — Leqembi and donanemab — are the first to offer real hope of
slowing the fatal disease for the 6.5 million Americans living
with ... |
Black patients face delays in Alzheimer's diagnosis, research finds
Previous studies have shown that Black patients are at increased risk of Alzheimer's disease and other types of dementia. They are ... View article...